In the last 12 months, insiders at Century Therapeutics, Inc. ($IPSC) filed 119 transactions with the SEC: 4 open-market purchases totaling $104,590 and 49 sales totaling $500,936. Net insider sentiment: net selling.
Century Therapeutics, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Pfeiffenberger Brent (President and CEO) — 20 transactions totaling $665,422
- Farid Adrienne (Chief Operations Officer) — 22 transactions totaling $352,725
- Russotti Gregory (See Remarks) — 20 transactions totaling $110,474
- Cowan Chad (Chief Scientific Officer) — 11 transactions totaling $57,498
- Carr Douglas (SVP Finance & Operations) — 24 transactions totaling $51,586
View all SEC Filings for Century Therapeutics, Inc. (IPSC).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 7043 | $2.55 | 507,261.0000 | 86,556,515 | 1.37% | 0.01% |
| March 12, 2026 | Russotti Gregory | See Remarks | S | Common Stock | 10076 | $2.55 | 608,200.0000 | 86,556,515 | 1.63% | 0.01% |
| March 11, 2026 | Cowan Chad | Chief Scientific Officer | F | Common Stock | 1431 | $2.73 | 1,187,742.0000 | 86,464,066 | 0.12% | 0.00% |
| March 11, 2026 | Pfeiffenberger Brent | President and CEO | F | Common Stock | 55397 | $2.73 | 3,710,958.0000 | 86,464,066 | 1.47% | 0.06% |
| March 9, 2026 | Russotti Gregory | See Remarks | S | Common Stock | 479 | $2.54 | 618,276.0000 | 86,464,066 | 0.08% | 0.00% |
| March 9, 2026 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 247 | $2.54 | 514,304.0000 | 86,464,066 | 0.05% | 0.00% |
| March 6, 2026 | Pfeiffenberger Brent | President and CEO | F | Common Stock | 463 | $2.56 | 3,766,355.0000 | 86,464,066 | 0.01% | 0.00% |
| Feb. 13, 2026 | Pfeiffenberger Brent | President and CEO | F | Common Stock | 31172 | $1.75 | 3,766,818.0000 | 86,464,066 | 0.82% | 0.04% |
| Feb. 3, 2026 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 323 | $1.82 | 514,551.0000 | 86,464,066 | 0.06% | 0.00% |
| Feb. 2, 2026 | Carr Douglas | SVP Finance & Operations | A | Stock Option (right to buy) | 225000 | $0.00 | 225,000.0000 | 86,464,066 | 9999.99% | 0.26% |
| Feb. 2, 2026 | Cowan Chad | Chief Scientific Officer | A | Common Stock | 135000 | $0.00 | 1,189,173.0000 | 86,464,066 | 12.81% | 0.16% |
| Feb. 2, 2026 | Russotti Gregory | See Remarks | A | Common Stock | 135000 | $0.00 | 618,755.0000 | 86,464,066 | 27.91% | 0.16% |
| Feb. 2, 2026 | Cowan Chad | Chief Scientific Officer | A | Stock Option (right to buy) | 265000 | $0.00 | 265,000.0000 | 86,464,066 | 9999.99% | 0.31% |
| Feb. 2, 2026 | Carr Douglas | SVP Finance & Operations | A | Common Stock | 110000 | $0.00 | 514,874.0000 | 86,464,066 | 27.17% | 0.13% |
| Feb. 2, 2026 | Pfeiffenberger Brent | President and CEO | A | Stock Option (right to buy) | 945000 | $0.00 | 945,000.0000 | 86,464,066 | 9999.99% | 1.09% |
| Feb. 2, 2026 | Pfeiffenberger Brent | President and CEO | A | Common Stock | 475000 | $0.00 | 3,797,990.0000 | 86,464,066 | 14.29% | 0.55% |
| Feb. 2, 2026 | Russotti Gregory | See Remarks | A | Stock Option (right to buy) | 265000 | $0.00 | 265,000.0000 | 86,464,066 | 9999.99% | 0.31% |
| Jan. 2, 2026 | Cowan Chad | Chief Scientific Officer | F | Common Stock | 1611 | $1.00 | 1,054,173.0000 | 86,464,066 | 0.15% | 0.00% |
| Dec. 22, 2025 | Cowan Chad | Chief Scientific Officer | P | Common Stock | 58060 | $0.85 | 1,055,784.0000 | 86,464,066 | 5.82% | 0.07% |
| Dec. 12, 2025 | Pfeiffenberger Brent | President and CEO | P | Common Stock | 52000 | $0.58 | 3,322,990.0000 | 86,464,066 | 1.59% | 0.06% |
| Dec. 10, 2025 | Pfeiffenberger Brent | President and CEO | F | Common Stock | 463 | $0.53 | 3,270,990.0000 | 86,464,066 | 0.01% | 0.00% |
| Dec. 9, 2025 | Lee Han Myung | Not found | A | Stock Option (right to buy) | 88000 | $0.00 | 88,000.0000 | 86,464,066 | 9999.99% | 0.10% |
| Dec. 8, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 257 | $0.53 | 404,874.0000 | 86,464,066 | 0.06% | 0.00% |
| Dec. 8, 2025 | Russotti Gregory | See Remarks | S | Common Stock | 526 | $0.53 | 483,755.0000 | 86,464,066 | 0.11% | 0.00% |
| Nov. 20, 2025 | Cowan Chad | Chief Scientific Officer | S | Common Stock | 5462 | $0.50 | 997,724.0000 | 86,464,066 | 0.54% | 0.01% |
| Nov. 19, 2025 | Pfeiffenberger Brent | President and CEO | P | Common Stock | 35000 | $0.50 | 3,271,453.0000 | 86,464,066 | 1.08% | 0.04% |
| Nov. 17, 2025 | Pfeiffenberger Brent | President and CEO | S | Common Stock | 32456 | $0.45 | 3,236,453.0000 | 86,464,066 | 0.99% | 0.04% |
| Nov. 3, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 292 | $0.59 | 405,131.0000 | 86,464,066 | 0.07% | 0.00% |
| Sept. 18, 2025 | Cowan Chad | Chief Scientific Officer | A | Common Stock | 762543 | $0.00 | 1,003,186.0000 | 86,238,084 | 316.88% | 0.88% |
| Sept. 8, 2025 | Pfeiffenberger Brent | President and CEO | S | Common Stock | 488 | $0.50 | 3,268,909.0000 | 86,238,084 | 0.01% | 0.00% |
| Sept. 8, 2025 | Russotti Gregory | See Remarks | S | Common Stock | 539 | $0.50 | 484,281.0000 | 86,238,084 | 0.11% | 0.00% |
| Sept. 8, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 263 | $0.50 | 405,423.0000 | 86,238,084 | 0.06% | 0.00% |
| Aug. 14, 2025 | Pfeiffenberger Brent | President and CEO | A | Common Stock | 1587614 | $0.00 | 3,269,397.0000 | 86,238,084 | 94.40% | 1.84% |
| Aug. 4, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 296 | $0.53 | 405,686.0000 | 86,238,084 | 0.07% | 0.00% |
| June 12, 2025 | JIMENEZ JOSEPH | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 12, 2025 | Riva Alessandro | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 12, 2025 | Carlo Rizzuto | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 12, 2025 | Blackwell Kimberly | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 12, 2025 | BUTITTA CYNTHIA M | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 12, 2025 | Walbert Timothy P | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 12, 2025 | Quimi Daphne | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 86,098,619 | 9999.99% | 0.05% |
| June 9, 2025 | Russotti Gregory | See Remarks | S | Common Stock | 526 | $0.62 | 484,820.0000 | 86,098,619 | 0.11% | 0.00% |
| June 9, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 4904 | $0.62 | 405,982.0000 | 86,098,619 | 1.19% | 0.01% |
| June 9, 2025 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 552 | $0.62 | 250,141.0000 | 86,098,619 | 0.22% | 0.00% |
| June 9, 2025 | Pfeiffenberger Brent | President and CEO | S | Common Stock | 475 | $0.62 | 1,681,783.0000 | 86,098,619 | 0.03% | 0.00% |
| May 16, 2025 | Pfeiffenberger Brent | President and CEO | S | Common Stock | 29552 | $0.55 | 1,682,258.0000 | 86,098,619 | 1.73% | 0.03% |
| May 5, 2025 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1024 | $0.55 | 250,693.0000 | 86,098,619 | 0.41% | 0.00% |
| May 5, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 295 | $0.55 | 410,886.0000 | 86,098,619 | 0.07% | 0.00% |
| March 10, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 1240 | $0.62 | 315,556.0000 | 78,648,958 | 0.39% | 0.00% |
| March 11, 2025 | Farid Adrienne | Chief Operations Officer | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 78,648,958 | 9999.99% | 0.15% |
| March 11, 2025 | Farid Adrienne | Chief Operations Officer | A | Common Stock | 120000 | $0.00 | 251,717.0000 | 78,648,958 | 91.10% | 0.15% |
| March 10, 2025 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 2359 | $0.62 | 131,717.0000 | 78,648,958 | 1.76% | 0.00% |
| March 11, 2025 | Russotti Gregory | See Remarks | A | Stock Option (right to buy) | 120000 | $0.00 | 120,000.0000 | 78,648,958 | 9999.99% | 0.15% |
| March 11, 2025 | Russotti Gregory | See Remarks | A | Common Stock | 120000 | $0.00 | 485,346.0000 | 78,648,958 | 32.85% | 0.15% |
| March 10, 2025 | Russotti Gregory | See Remarks | S | Common Stock | 2360 | $0.62 | 365,346.0000 | 78,648,958 | 0.64% | 0.00% |
| March 11, 2025 | Pfeiffenberger Brent | President and CEO | A | Stock Option (right to buy) | 521500 | $0.00 | 521,500.0000 | 78,648,958 | 9999.99% | 0.66% |
| March 10, 2025 | Pfeiffenberger Brent | President and CEO | S | Common Stock | 2235 | $0.62 | 1,190,310.0000 | 78,648,958 | 0.19% | 0.00% |
| March 11, 2025 | Carr Douglas | SVP Finance & Operations | A | Stock Option (right to buy) | 95625 | $0.00 | 95,625.0000 | 78,648,958 | 9999.99% | 0.12% |
| March 11, 2025 | Carr Douglas | SVP Finance & Operations | A | Common Stock | 95625 | $0.00 | 411,181.0000 | 78,648,958 | 30.30% | 0.12% |
| March 11, 2025 | Cowan Chad | Chief Scientific Officer | A | Common Stock | 19500 | $0.00 | 241,003.0000 | 78,648,958 | 8.80% | 0.02% |
| March 11, 2025 | Cowan Chad | Chief Scientific Officer | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,648,958 | 9999.99% | 0.02% |
| March 11, 2025 | Pfeiffenberger Brent | President and CEO | A | Common Stock | 521500 | $0.00 | 1,711,810.0000 | 78,648,958 | 43.81% | 0.66% |
| March 11, 2025 | Conn Morgan | Chief Finanical Officer | A | Common Stock | 19500 | $0.00 | 79,648.0000 | 78,648,958 | 32.42% | 0.02% |
| March 11, 2025 | Conn Morgan | Chief Finanical Officer | A | Stock Option (right to buy) | 19500 | $0.00 | 19,500.0000 | 78,648,958 | 9999.99% | 0.02% |
| Feb. 18, 2025 | Pfeiffenberger Brent | President and CEO | S | Common Stock | 34712 | $0.78 | 1,192,545.0000 | 78,648,958 | 2.83% | 0.04% |
| Feb. 3, 2025 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1054 | $0.78 | 134,076.0000 | 78,648,958 | 0.78% | 0.00% |
| Feb. 3, 2025 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 351 | $0.78 | 316,796.0000 | 78,648,958 | 0.11% | 0.00% |
| Dec. 4, 2024 | Pfeiffenberger Brent | President and CEO | F | Common Stock | 243447 | $1.44 | 1,227,257.0000 | 84,704,352 | 16.55% | 0.29% |
| Nov. 4, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1033 | $1.23 | 135,130.0000 | 84,704,352 | 0.76% | 0.00% |
| Nov. 1, 2024 | Carr Douglas | SVP Finance & Operations | F | Common Stock | 16611 | $1.26 | 317,430.0000 | 84,704,352 | 4.97% | 0.02% |
| Nov. 4, 2024 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 283 | $1.23 | 317,147.0000 | 84,704,352 | 0.09% | 0.00% |
| Oct. 14, 2024 | Conn Morgan | Chief Finanical Officer | A | Stock Option (right to buy) | 360890 | $0.00 | 360,890.0000 | 84,704,352 | 9999.99% | 0.43% |
| Oct. 14, 2024 | Conn Morgan | Chief Finanical Officer | A | Common Stock | 60148 | $0.00 | 60,148.0000 | 84,704,352 | 9999.99% | 0.07% |
| Oct. 1, 2024 | Cowan Chad | Chief Scientific Officer | A | Stock Option (right to buy) | 446250 | $0.00 | 446,250.0000 | 84,704,352 | 9999.99% | 0.53% |
| Oct. 1, 2024 | Cowan Chad | Chief Scientific Officer | A | Common Stock | 74376 | $0.00 | 221,503.0000 | 84,704,352 | 50.55% | 0.09% |
| Sept. 12, 2024 | Quimi Daphne | Director | P | Common Stock | 5000 | $1.53 | 5,000.0000 | 82,092,167 | 9999.99% | 0.01% |
| Aug. 5, 2024 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 289 | $1.83 | 334,041.0000 | 82,092,167 | 0.09% | 0.00% |
| Aug. 5, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1073 | $1.83 | 136,163.0000 | 82,092,167 | 0.78% | 0.00% |
| July 26, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 586 | $2.50 | 367,706.0000 | 82,092,167 | 0.16% | 0.00% |
| July 24, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 1600 | $2.52 | 368,292.0000 | 82,092,167 | 0.43% | 0.00% |
| July 23, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 200 | $2.50 | 369,892.0000 | 82,092,167 | 0.05% | 0.00% |
| June 20, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 5000 | $2.84 | 370,092.0000 | 62,296,637 | 1.33% | 0.01% |
| June 20, 2024 | Quimi Daphne | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 20, 2024 | JIMENEZ JOSEPH | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 20, 2024 | Walbert Timothy P | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 20, 2024 | BUTITTA CYNTHIA M | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 20, 2024 | Riva Alessandro | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 20, 2024 | Carlo Rizzuto | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 20, 2024 | Blackwell Kimberly | Director | A | Stock Option (right to buy) | 44000 | $0.00 | 44,000.0000 | 62,296,637 | 9999.99% | 0.07% |
| June 7, 2024 | Carr Douglas | SVP Finance & Operations | A | Common Stock | 17007 | $0.00 | 334,330.0000 | 62,296,637 | 5.36% | 0.03% |
| June 5, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 5000 | $3.00 | 375,092.0000 | 62,296,637 | 1.32% | 0.01% |
| May 20, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 5000 | $3.00 | 380,092.0000 | 62,296,637 | 1.30% | 0.01% |
| May 6, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 5000 | $3.12 | 385,092.0000 | 62,296,637 | 1.28% | 0.01% |
| May 3, 2024 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 257 | $3.11 | 317,323.0000 | 62,296,637 | 0.08% | 0.00% |
| May 3, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 913 | $3.11 | 137,236.0000 | 62,296,637 | 0.66% | 0.00% |
| April 22, 2024 | Russotti Gregory | See Remarks | S | Common Stock | 5000 | $3.10 | 390,092.0000 | 62,296,637 | 1.27% | 0.01% |
| March 7, 2024 | Pfeiffenberger Brent | President and CEO | A | Common Stock | 17425 | $0.00 | 1,470,704.0000 | 59,314,389 | 1.20% | 0.03% |
| March 7, 2024 | Pfeiffenberger Brent | President and CEO | A | Stock Option (right to buy) | 104550 | $0.00 | 104,550.0000 | 59,314,389 | 9999.99% | 0.18% |
| March 7, 2024 | Farid Adrienne | Chief Operations Officer | A | Stock Option (right to buy) | 146000 | $0.00 | 146,000.0000 | 59,314,389 | 9999.99% | 0.25% |
| March 7, 2024 | Levitsky Hyam | President of R&D | A | Stock Option (right to buy) | 146000 | $0.00 | 146,000.0000 | 59,314,389 | 9999.99% | 0.25% |
| March 7, 2024 | Levitsky Hyam | President of R&D | A | Common Stock | 24000 | $0.00 | 560,544.0000 | 59,314,389 | 4.47% | 0.04% |
| March 7, 2024 | Farid Adrienne | Chief Operations Officer | A | Common Stock | 24000 | $0.00 | 138,149.0000 | 59,314,389 | 21.03% | 0.04% |
| March 7, 2024 | Russotti Gregory | See Remarks | A | Stock Option (right to buy) | 146000 | $0.00 | 146,000.0000 | 59,314,389 | 9999.99% | 0.25% |
| March 7, 2024 | Russotti Gregory | See Remarks | A | Common Stock | 24000 | $0.00 | 395,092.0000 | 59,314,389 | 6.47% | 0.04% |
| March 7, 2024 | Carr Douglas | SVP Finance & Operations | A | Stock Option (right to buy) | 81000 | $0.00 | 81,000.0000 | 59,314,389 | 9999.99% | 0.14% |
| March 7, 2024 | Carr Douglas | SVP Finance & Operations | A | Common Stock | 14000 | $0.00 | 317,580.0000 | 59,314,389 | 4.61% | 0.02% |
| March 7, 2024 | Farid Adrienne | Chief Operations Officer | M | Common Stock | 22831 | $1.03 | 136,980.0000 | 59,314,389 | 20.00% | 0.04% |
| March 7, 2024 | Farid Adrienne | Chief Operations Officer | M | Stock Option (right to buy) | 22831 | $0.00 | 168,655.0000 | 59,314,389 | 11.92% | 0.04% |
| March 6, 2024 | Farid Adrienne | Chief Operations Officer | M | Common Stock | 30684 | $1.03 | 144,833.0000 | 59,314,389 | 26.88% | 0.05% |
| March 6, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 30684 | $4.96 | 114,149.0000 | 59,314,389 | 21.19% | 0.05% |
| March 7, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 22831 | $5.14 | 114,149.0000 | 59,314,389 | 16.67% | 0.04% |
| March 6, 2024 | Farid Adrienne | Chief Operations Officer | M | Stock Option (right to buy) | 30684 | $0.00 | 191,486.0000 | 59,314,389 | 13.81% | 0.05% |
| Feb. 16, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 485 | $4.86 | 114,149.0000 | 59,314,389 | 0.42% | 0.00% |
| Feb. 16, 2024 | Farid Adrienne | Chief Operations Officer | M | Common Stock | 485 | $1.03 | 114,634.0000 | 59,314,389 | 0.42% | 0.00% |
| Feb. 16, 2024 | Farid Adrienne | Chief Operations Officer | M | Stock Option (right to buy) | 485 | $0.00 | 222,170.0000 | 59,314,389 | 0.22% | 0.00% |
| Feb. 5, 2024 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 643 | $3.84 | 304,137.0000 | 59,314,389 | 0.21% | 0.00% |
| Feb. 6, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 1784 | $4.49 | 114,149.0000 | 59,314,389 | 1.54% | 0.00% |
| Feb. 5, 2024 | Farid Adrienne | Chief Operations Officer | S | Common Stock | 2035 | $3.84 | 115,933.0000 | 59,314,389 | 1.73% | 0.00% |
| Feb. 6, 2024 | Carr Douglas | SVP Finance & Operations | S | Common Stock | 557 | $4.49 | 303,580.0000 | 59,314,389 | 0.18% | 0.00% |